Daruish M, Ambrogio F, Colagrande A, Marzullo A, Alaggio R, Trilli I
Dermatopathology (Basel). 2024; 11(1):112-123.
PMID: 38390852
PMC: 10885070.
DOI: 10.3390/dermatopathology11010010.
Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M
Cancer Genomics Proteomics. 2023; 20(4):363-374.
PMID: 37400148
PMC: 10320557.
DOI: 10.21873/cgp.20388.
Panagopoulos I, Heim S
Cancer Genomics Proteomics. 2022; 19(6):647-672.
PMID: 36316036
PMC: 9620447.
DOI: 10.21873/cgp.20349.
Latha K, Patel Y, Rao S, Watford W
Inflammation. 2022; 46(1):322-341.
PMID: 36227523
PMC: 9558022.
DOI: 10.1007/s10753-022-01736-8.
Bansod S, Dodhiawala P, Lim K
Cancers (Basel). 2021; 13(21).
PMID: 34771644
PMC: 8582583.
DOI: 10.3390/cancers13215481.
Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma.
Hao J, Cao Y, Yu H, Zong L, An R, Xue Y
Front Genet. 2021; 12:674613.
PMID: 34567061
PMC: 8461076.
DOI: 10.3389/fgene.2021.674613.
Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge L, Estania A, Guo Y, Liu W, Yang L
Theranostics. 2020; 10(18):8343-8364.
PMID: 32724474
PMC: 7381748.
DOI: 10.7150/thno.45848.
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Lehmann B, Shaver T, Johnson D, Li Z, Gonzalez-Ericsson P, Sanchez V
Mol Cancer Res. 2019; 17(9):1842-1853.
PMID: 31186280
PMC: 6726520.
DOI: 10.1158/1541-7786.MCR-19-0257.
TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.
Wang Y, Wang S, Kelly C, Feng H, Greenberg A, Sun X
Infect Immun. 2018; 86(8).
PMID: 29844241
PMC: 6056850.
DOI: 10.1128/IAI.00095-18.
Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages.
Chatterjee S, Talaat K, Van Seventer E, Feng C, Scott A, Jedlicka A
PLoS One. 2017; 12(6):e0179701.
PMID: 28658262
PMC: 5489173.
DOI: 10.1371/journal.pone.0179701.
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas.
Gruosso T, Garnier C, Abelanet S, Kieffer Y, Lemesre V, Bellanger D
Nat Commun. 2015; 6:8583.
PMID: 26456302
PMC: 4633961.
DOI: 10.1038/ncomms9583.
Involvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C.
Tsubota A, Mogushi K, Aizaki H, Miyaguchi K, Nagatsuma K, Matsudaira H
PLoS One. 2014; 9(5):e97078.
PMID: 24819603
PMC: 4018277.
DOI: 10.1371/journal.pone.0097078.
Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury F, Estrada L, Murray S, Forman J, Farrar J
PLoS One. 2014; 9(3):e92187.
PMID: 24642963
PMC: 3958505.
DOI: 10.1371/journal.pone.0092187.
RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
Taniguchi R, Fukushima H, Osawa K, Maruyama T, Yasuda H, Weih F
J Biol Chem. 2014; 289(11):7349-61.
PMID: 24488495
PMC: 3953251.
DOI: 10.1074/jbc.M113.538314.
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo.
Cesana D, Ranzani M, Volpin M, Bartholomae C, Duros C, Artus A
Mol Ther. 2014; 22(4):774-85.
PMID: 24441399
PMC: 3982501.
DOI: 10.1038/mt.2014.3.
TEC and MAPK Kinase Signalling Pathways in T helper (T) cell Development, T2 Differentiation and Allergic Asthma.
Kannan Y, Wilson M
J Clin Cell Immunol. 2013; Suppl 12:11.
PMID: 24116341
PMC: 3792371.
DOI: 10.4172/2155-9899.S12-011.
Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.
DeCicco-Skinner K, Jung S, Tabib T, Gwilliam J, Alexander H, Goodheart S
Carcinogenesis. 2013; 34(12):2789-98.
PMID: 24067898
PMC: 3845897.
DOI: 10.1093/carcin/bgt319.
Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice.
DeCicco-Skinner K, Nolan S, Deshpande M, Trovato E, Dempsey T, Wiest J
PLoS One. 2013; 8(2):e56212.
PMID: 23457529
PMC: 3574127.
DOI: 10.1371/journal.pone.0056212.
Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.
Kuroda Y, Hisatsune C, Mizutani A, Ogawa N, Matsuo K, Mikoshiba K
Mol Cell Biol. 2012; 32(14):2954-63.
PMID: 22615493
PMC: 3416192.
DOI: 10.1128/MCB.05611-11.
TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.
Jeong J, Bhatia A, Toth Z, Oh S, Inn K, Liao C
PLoS One. 2011; 6(1):e16205.
PMID: 21267413
PMC: 3022761.
DOI: 10.1371/journal.pone.0016205.